tetano
Editor, Senior Moderator
Gastroenterol Hepatol Bed Bench
. Winter 2022;15(1):9-14.
Association between viral hepatitis and increased risk of severe coronavirus disease 2019 (COVID-19) outcome: a systematic review and meta-analysis
Timotius Ivan Hariyanto[SUP] 1 [/SUP], Claudia Jodhinata[SUP] 1 [/SUP], Devina Adella Halim[SUP] 1 [/SUP], Andree Kurniawan[SUP] 2 [/SUP]
Affiliations
Abstract
Aim: The purpose of the current study is to analyze the potential association between viral hepatitis and the severity of COVID-19.
Background: Coronavirus disease 2019 (COVID-19) is a worldwide concern that has created major issues with many aspects. It is important to identify the risk factors for severe outcomes of this disease. To date, no association between viral hepatitis and severe COVID-19 has not been established.
Methods: Through November 5[SUP]th[/SUP], 2020, the databases of PubMed, Google Scholar, and medRxiv were systematically searched using specific keywords related to the focus of the study. All articles published on COVID-19 and viral hepatitis were retrieved. The Mantel-Haenszel formula with random-effects models was used to obtain the risk ratio (RR) along with its 95% confidence intervals (CIs) for dichotomous variables. The two-tailed p-value was set with a value ≤0.05 considered statistically significant. Restricted-maximum likelihood meta-regression was done for several variables, such as age, gender, hypertension, diabetes, and other liver disease.
Results: Analysis results included a total of 16 studies with a total of 14,682 patients. Meta-analysis showed that viral hepatitis increases the risk of developing severe COVID-19 (RR 1.68 (95% CI 1.26 - 2.22), p = 0.0003, I [SUP]2[/SUP] = 21%, random-effect modeling). According to the meta-regression analysis, the association between viral hepatitis and severe COVID-19 was not influenced by age (p = 0.067), diabetes (p = 0.057), or other liver disease (p = 0.646).
Conclusion: An increase of severe COVID-19 risk is associated with viral hepatitis. To reduce the risk of COVID-19, patients with viral hepatitis should be monitored carefully.
Keywords: COVID-19; Coronavirus; Hepatitis; Liver disease; Viral infection.
. Winter 2022;15(1):9-14.
Association between viral hepatitis and increased risk of severe coronavirus disease 2019 (COVID-19) outcome: a systematic review and meta-analysis
Timotius Ivan Hariyanto[SUP] 1 [/SUP], Claudia Jodhinata[SUP] 1 [/SUP], Devina Adella Halim[SUP] 1 [/SUP], Andree Kurniawan[SUP] 2 [/SUP]
Affiliations
- PMID: 35611257
- PMCID: PMC9123631
Abstract
Aim: The purpose of the current study is to analyze the potential association between viral hepatitis and the severity of COVID-19.
Background: Coronavirus disease 2019 (COVID-19) is a worldwide concern that has created major issues with many aspects. It is important to identify the risk factors for severe outcomes of this disease. To date, no association between viral hepatitis and severe COVID-19 has not been established.
Methods: Through November 5[SUP]th[/SUP], 2020, the databases of PubMed, Google Scholar, and medRxiv were systematically searched using specific keywords related to the focus of the study. All articles published on COVID-19 and viral hepatitis were retrieved. The Mantel-Haenszel formula with random-effects models was used to obtain the risk ratio (RR) along with its 95% confidence intervals (CIs) for dichotomous variables. The two-tailed p-value was set with a value ≤0.05 considered statistically significant. Restricted-maximum likelihood meta-regression was done for several variables, such as age, gender, hypertension, diabetes, and other liver disease.
Results: Analysis results included a total of 16 studies with a total of 14,682 patients. Meta-analysis showed that viral hepatitis increases the risk of developing severe COVID-19 (RR 1.68 (95% CI 1.26 - 2.22), p = 0.0003, I [SUP]2[/SUP] = 21%, random-effect modeling). According to the meta-regression analysis, the association between viral hepatitis and severe COVID-19 was not influenced by age (p = 0.067), diabetes (p = 0.057), or other liver disease (p = 0.646).
Conclusion: An increase of severe COVID-19 risk is associated with viral hepatitis. To reduce the risk of COVID-19, patients with viral hepatitis should be monitored carefully.
Keywords: COVID-19; Coronavirus; Hepatitis; Liver disease; Viral infection.